SEC Form 4 · accession 0001493152-16-015976
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Avtar S Dhillon
Director
Period of report
Dec 14, 2016
Accepted (ET)
Dec 16, 2016 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2,F1 | $4.20 | Dec 14, 2016 | D | 5,000 | D | — | Apr 25, 2022 | Common Stock | 5,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F3 | $5.00 | Dec 14, 2016 | D | 5,000 | D | — | Apr 15, 2023 | Common Stock | 5,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F4 | $16.10 | Dec 14, 2016 | D | 12,500 | D | — | Mar 7, 2024 | Common Stock | 12,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F5 | $7.60 | Dec 14, 2016 | D | 12,500 | D | — | Mar 3, 2025 | Common Stock | 12,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F6 | $5.76 | Dec 14, 2016 | D | 500,000 | D | — | Aug 21, 2025 | Common Stock | 500,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2,F7 | $1.29 | Dec 14, 2016 | A | 265,416 | A | — | Dec 14, 2026 | Common Stock | 265,416 | 265,416 | D |
Explanation of responses
- F1These stock options were fully vested on April 25, 2013, the first anniversary of the grant date.
- F2On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share.
- F3These stock options were fully vested on April 15, 2014, the first anniversary of the grant date.
- F4These stock options were fully vested on March 7, 2015, the first anniversary of the grant date.
- F5These stock options were fully vested on March 3, 2016, the first anniversary of the grant date.
- F6These stock options were fully vested on August 21, 2016, the first anniversary of the grant date.
- F7The stock options granted on December 14, 2016 will vest on the following schedule: 25% on grant date; 1/12th of the remaining 75% vesting on each of the 12 subsequent monthly anniversaries of the grant date.